Do U.S. Regulations allow more than minor increase over minimal risk pediatric research? Should they?

IRB Ethics and Human Research

Volumn 35, Issue 6, 2013, Pages 1-8

  Wendler, David ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILD WELFARE; ETHICS; GOVERNMENT REGULATION; HUMAN; HUMAN EXPERIMENT; LEGAL ASPECT; MEDICAL RESEARCH; PEDIATRICS; PROFESSIONAL STANDARD; RISK ASSESSMENT; UNITED STATES;

BIOMEDICAL RESEARCH; CHILD; CHILD WELFARE; ETHICS COMMITTEES, RESEARCH; GOVERNMENT REGULATION; HUMAN EXPERIMENTATION; HUMANS; PEDIATRICS; RISK ASSESSMENT; UNITED STATES;

EID: 84897018542     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Tait AR. Weighing the risks and benefits of pediatric research: A risky business. Archives of Pediatric and Adolescent Medicine 2010;164:579-581;
2. Ross LF, Nelson RM. Pediatric research and the federal minimal risk standard. JAMA 2006;295(7):759-760.
3. U. S. Department of Health and Humar Services. Protection of Human Subjects. 45 CFR 46;
4. U. S. Food and Drug Administration Protection of Human Subjects. 21 CFR 50.
5. See ref. 2, 45 CFR 46.406.
6. See ref. 2, 21 CFR 50.54;
7. Field MJ, Behrman RE. Ethical Conduct of Clinical Research Involving Children. Washington DC: National Academies Press, 2004, p. 145.
8. See ref. 4, Field and Behrman, 2004.
9. Final report to NHRPAC from Children's Workgroup. Clarifying Specific Portior of 45 CFR 46 Subpart D that Governs Children's Research, http://www.hhs.gov/ohrp/archi ve/nhrpac/documents/nhrpac 16.pdf.
10. U. S. Department of Health and Humar Services. Children Involved as Subjects in Research: Guidance on the HHS 45 CFR 46.407
11. ("407") Review Process, May 26, 2005. http://www.hhs.gov/ohrp/ policy/populations/guidance-407process.html.
12. Algorithm for Subpart D Analysis. http://www.hhs.gov/ohrp/sachrp/ appendixa.pdf;
13. SACHRP letter to HHS secretary on children's research, http://www.hhs.gov/ohrp/sachrp/pages3-7fromo8112004sec.pdf.
14. U. S. Department of Health and Human Services. Advance Notice of Proposed Rulemaking: Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators, http://www.gpo. gov/fdsys/pkg/FR-201 i-07-26/html/20i 1-18792.htm.
15. The U. S. regulations include an analogous category for research with pregnant women, fetuses, and neonates, 45 CFR 46.207, but not for research with prisoners.
16. 45 CFR 46.405 (b).
17. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Report and Recommendations on Research Involving Children, DHEW publication (05) 77-0004. U. S. Department of Health, Education and Welfare, 1977;
18. Jonsen AR. Research involving children: Recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Pediatrics 1978;62:131-136.
19. See ref. 12, National Commission.
20. See ref. 12, National Commission.
21. See ref. 12, National Commission.
22. Kopelman LM. Minimal risk as an international ethical standard in research. Journal of Medicine and Philosophy 2004;529:351-378;
23. Rid A, Emanuel EJ, Wendler D. Evaluating the risks of clinical research. JAMA 2010;304(i3):1472-i479;
24. Ross LF, Nelson RM. Pediatric research and the federal minimal risk standard. JAMA 2006;295(7):759; author reply 759-760;
25. Kopelman LM, Murphy TF. Ethical concerns about federal approval of risky pediatric studies. Pediatrics 2004;113:1783-1789;
26. Ross LF. Children in Medical Research: Access versus Protection. New York: Oxford University Press, 2006.
27. Fisher CB, Kornetsky SZ. SACHRP recommendations for review of children's research requiring DHHS secretary's approval. IRB: Ethics & Human Research 2005;27(3):1-7.
28. Fisher CB, Kornetsky SZ, Prentice ED. Determining risk in pediatric research with no prospect of direct benefit: Time for a national consensus on the interpretation of federal regulations. American Journal of Bioethics 2007;7:5-10.
29. Resnik DB. Eliminating the daily risks standard from the definition of minimal risk. Journal of Medical Ethics 2005;31:35-38.
30. Wendler D. Protecting subjects who cannot give consent: Toward a better standard for "minimal" risks. Hastings Center Report 2005;35(5):37-43.
31. Nelson RM, Ross LF. In defense of a single standard of research risk for all children. Journal of Pediatrics 2005;147:565 566;
32. Freedman B, Fuks A, Weijer C. In loco parentis: Minimal risk as an ethical threshold for research upon children. Hastings Center Report 1993;13(2):13-9.
33. Grimes v. Kennedy Krieger Institute, Inc., 782 A. 2d 807 (Md. Ct. of App. 2001, reconsideration denied, Oct. 11, 2001);
34. Lenk C, Radenbach K, Dahl M, Wiesemann C, Claudia. Non-therapeutic research with minors: How do chairpersons of German research ethics committees decide? Journal of Medical and Ethics 2004;30:85-87.
35. See ref. 21, Freedman et al. 1993.
36. Pediatric Advisory Committee. Children's Oncology Group protocol ASCT0631: A phase III randomized trial of granulocyte colony stimulating factor (G-CSF) stimulated bone marrow vs. conventional bone marrow as a stem cell source in matched sibling donor transplantation. December 9, 2008. http://www.fda.gov/ohrms/dockets/ac/08/transcripts/2oo8-44o6t-oi.pdf.
37. Ramsey P. The enforcement of morals: Nontherapeutic research on children: A reply to Richard McCormick. Hastings Center Report 1976 (4); 6:21-30;
38. Sammons HM, Malhotra J, Choonara I, Sitar DS, Matsui D, Rieder MJ. Survey of pediatricians in Canada and Europe. European Journal of Clinical Pharmacology 2007;63:431-436.
39. Presidential Commission for the Study of Bioethical Issues. Meeting ten: Aug. 1-2, 2012 in Washington, D. C.. http://bioethics. gov/cms/meeting-1 o.
40. Coleman DL. The legal ethics of pediatric research. Duke Law Journal 2007;57:517-624.
41. Ondrusek N, Abramovitch R, Pencharz P, Koren G. Empirical examination of the ability of children to consent to clinical research. Journal of Medical Ethics 1998;24:158-165;
42. Weithorn LA, Campbell S. The competency of children and adolescents to make informed treatment decisions. Child Development 1982;53:1589-1598;
43. Susman EJ, Dorn LD, Fletcher JC. Participation in biomedical research: The consent process as viewed by children, adolescents, young adults, and physicians. Journal of Pediatrics 1992;12:547-552.
44. Ackerman TF. Moral duties of parents and nontherapeutic clinical research procedures involving children. Bioethics Quarterly 1980;2:94-111.
45. King N. Defining and describing benefit appropriately in clinical trials. Journal of Law, Medicine, and Ethics 2005;28:332-343